Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Schupsky

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Life Sciences|January 1, 1994
Opioid mu receptor subtypes (possibly mu 1 and mu 2) revealed by morphine-induced antinociception vs endothelin-1 in recombinant inbred CXBK miceR B Raffa, J J Schupsky
Prostaglandins|August 1, 1984
Mechanism of action of suprofen, a new peripheral analgesic, as demonstrated by its effects on several nociceptive mediatorsB Dubinsky, J J Schupsky
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Endothelin-induced nociception in mice: mediation by ETA and ETB receptorsR B Raffa, J J Schupsky, H I Jacoby
Life Sciences|January 1, 1994
Etonitazene-induced antinociception in mu1 opioid receptor deficient CXBK mice: evidence for a role for mu2 receptors in supraspinal antinociceptionC D Connelly, R P Martinez, J J Schupsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociceptionE E Codd, R P Shank, J J Schupsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic modelR B Raffa, J J Schupsky, D K Lee, et al.
Life Sciences|January 1, 1991
Endothelin-1-induced nociceptionR B Raffa, J J Schupsky, R P Martinez, et al.
Oncology Research|February 26, 2000
Growth inhibition of a human ovarian tumor by a novel paclitaxel derivative in SCID miceI Ahmad, G R Masters, J J Schupsky, et al.
Cancer Research|May 15, 1997
Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholineI Ahmad, J J Filep, J C Franklin, et al.
Journal of Medicinal Chemistry|May 9, 1998
Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivativesB E Maryanoff, M J Costanzo, S O Nortey, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Life Sciences|January 1, 1994
Opioid mu receptor subtypes (possibly mu 1 and mu 2) revealed by morphine-induced antinociception vs endothelin-1 in recombinant inbred CXBK miceR B Raffa, J J Schupsky
Prostaglandins|August 1, 1984
Mechanism of action of suprofen, a new peripheral analgesic, as demonstrated by its effects on several nociceptive mediatorsB Dubinsky, J J Schupsky
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1996
Endothelin-induced nociception in mice: mediation by ETA and ETB receptorsR B Raffa, J J Schupsky, H I Jacoby
Life Sciences|January 1, 1994
Etonitazene-induced antinociception in mu1 opioid receptor deficient CXBK mice: evidence for a role for mu2 receptors in supraspinal antinociceptionC D Connelly, R P Martinez, J J Schupsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1995
Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociceptionE E Codd, R P Shank, J J Schupsky, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1996
Characterization of endothelin-induced nociception in mice: evidence for a mechanistically distinct analgesic modelR B Raffa, J J Schupsky, D K Lee, et al.
Life Sciences|January 1, 1991
Endothelin-1-induced nociceptionR B Raffa, J J Schupsky, R P Martinez, et al.
Oncology Research|February 26, 2000
Growth inhibition of a human ovarian tumor by a novel paclitaxel derivative in SCID miceI Ahmad, G R Masters, J J Schupsky, et al.
Cancer Research|May 15, 1997
Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholineI Ahmad, J J Filep, J C Franklin, et al.
Journal of Medicinal Chemistry|May 9, 1998
Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivativesB E Maryanoff, M J Costanzo, S O Nortey, et al.
Pageof 2